Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA), Division of Epidemiology, University of Utah School of Medicine, 295 Chipeta Way, Salt Lake City, UT, 84132, USA.
Department of Obstetrics and Gynecology, University of Utah School of Medicine, Division of Maternal Fetal Medicine, Salt Lake City, UT, 84132, USA.
Addict Sci Clin Pract. 2020 Oct 31;15(1):33. doi: 10.1186/s13722-020-00206-6.
Opioid use disorder (OUD) among women delivering at a hospital has increased 400% from 1999-2014 in the United States. From the years 2007 to 2016, opioid-related mortality during pregnancy increased over 200%, and drug-overdose deaths made up nearly 10% of all pregnancy-associated mortality in 2016 in the US. Disproportionately higher rates of neonatal opioid withdrawal syndrome (NOWS) have been reported in rural areas of the country, suggesting that perinatal OUD is a pressing issue among these communities. There is an urgent need for comprehensive, evidence-based treatment services for pregnant women experiencing OUD. The purpose of this article is to describe a study protocol aimed at developing and evaluating a perinatal OUD curriculum, enhancing evidence-based perinatal OUD treatment in a rural setting, and evaluating the implementation of such collaborative care for perinatal OUD.
This two-year study employed a one group, repeated measures, hybrid type-1 effectiveness-implementation design. This study delivered interventions at 2 levels, both targeting improvement of care for pregnant women with OUD. The first area of focus was at the community healthcare provider-level, which aimed to evaluate the acceptability and feasibility of perinatal OUD education across time and to improve provider education by increasing knowledge specific to: MOUD provision; screening, brief intervention, and referral to treatment (SBIRT) utilization; and NOWS treatment. The second area of intervention focus was at the patient-level, which assessed the preliminary effect of perinatal OUD provider education in promoting illicit opioid abstinence and treatment engagement among pregnant women with OUD. We adopted constructs from the Consolidated Framework for Implementation Research (CFIR) to assess contextual factors that may influence implementation, and the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) model to comprehensively evaluate implementation outcomes.
This article presents the protocol of an implementation study that is employing the CFIR and RE-AIM frameworks to implement and evaluate a perinatal OUD education and service coordination program in two rural counties. This protocol could serve as a model for clinicians and researchers seeking to implement improvements in perinatal care for women with OUD in other rural communities. Trial registration NCT04448015 clinicaltrials.gov.
在美国,1999 年至 2014 年期间,在医院分娩的女性中阿片类药物使用障碍(OUD)增加了 400%。2007 年至 2016 年期间,怀孕期间与阿片类药物相关的死亡率增加了 200%以上,2016 年美国与怀孕相关的所有死亡人数中,药物过量死亡人数占近 10%。该国农村地区报告的新生儿阿片类药物戒断综合征(NOWS)发生率更高,这表明围产期 OUD 是这些社区的一个紧迫问题。迫切需要为患有 OUD 的孕妇提供全面、基于证据的治疗服务。本文旨在描述一项研究方案,旨在开发和评估围产期 OUD 课程,在农村环境中加强基于证据的围产期 OUD 治疗,并评估针对围产期 OUD 的这种合作护理的实施情况。
这项为期两年的研究采用了一组重复测量、混合 1 型有效性实施设计。该研究在两个层面上进行干预,均旨在改善患有 OUD 的孕妇的护理。第一个重点领域是社区医疗保健提供者层面,旨在评估围产期 OUD 教育在不同时间内的可接受性和可行性,并通过增加特定于以下方面的知识来提高提供者的教育水平:MOUD 的提供;筛查、简短干预和转介治疗(SBIRT)的利用;以及 NOWS 的治疗。第二个干预重点领域是患者层面,评估围产期 OUD 提供者教育在促进患有 OUD 的孕妇戒断非法阿片类药物和接受治疗方面的初步效果。我们采用实施研究综合框架(CFIR)的构建来评估可能影响实施的背景因素,并采用 Reach、Effectiveness、Adoption、Implementation 和 Maintenance(RE-AIM)模型来全面评估实施结果。
本文介绍了一项实施研究的方案,该研究采用 CFIR 和 RE-AIM 框架在两个农村县实施和评估围产期 OUD 教育和服务协调计划。该方案可以为寻求在其他农村社区改善患有 OUD 的孕妇围产期护理的临床医生和研究人员提供模型。试验注册 NCT04448015 clinicaltrials.gov。